CEO Ben Nikolaevsky shares the background of Pure Extract's successful management team.
CEO Dr. Joseph Tucker explains his view of the landscape in the psychedelics industry over the course of 2021.
Thought Leader Dr. Joseph Tucker discusses how the psychedelics industry will be impacted by the recent order by Health Canada.
Dr. Joseph Tucker, CEO of MagicMed Industries, shares insight into its very successful recent capital raise.
CEO Dr. Joseph Tucker explains MagicMed's readiness to engage in psilocybin and DMT business partnerships via its Psybrary.
CEO Dr. Joseph Tucker explains their proprietary asset, the Psybrary.
CEO Dr. Joseph Tucker discusses the unique approach his company has to the psychedelics industry.
CEO Dr. Joseph Tucker discusses MagicMed's business model.
Pure Extracts CEO Ben Nikolaevsky shares the company's plans to move to functional, then hallucinogenic mushrooms.
CEO Ben Nikolaevsky shares the factors behind the 'perfect storm' in the extraction market that Pure Extracts is able to benefit from.